المؤلفون: Tungjitviboonkun S; University of California San Francisco, San Francisco, United States. Songphol157@gmail.com.; Division of Hematology, Department of Medicine, Sirindhorn Hospital, Bangkok, Thailand. Songphol157@gmail.com., Bumrungratanayos N; HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand., Jitwimungsanon J; Division of Hematology, Department of Medicine, Sirindhorn Hospital, Bangkok, Thailand., Kheamakulvanich T; Koh Sichang Hospital, Chonburi, Thailand., Siramongkholkarn S; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

المصدر: Annals of hematology [Ann Hematol] 2024 Sep; Vol. 103 (9), pp. 3357-3368. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Aminopyridines*/therapeutic use , Aminopyridines*/adverse effects , Morpholines*/therapeutic use , Morpholines*/adverse effects , Oxazines*/therapeutic use , Oxazines*/adverse effects , Purpura, Thrombocytopenic, Idiopathic*/drug therapy , Purpura, Thrombocytopenic, Idiopathic*/blood , Pyridines*/therapeutic use , Pyridines*/adverse effects , Pyrimidines*/therapeutic use , Pyrimidines*/adverse effects, Adult ; Humans ; Platelet Count ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Syk Kinase/antagonists & inhibitors ; Treatment Outcome

المؤلفون: Ferreira JCC; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.; IBS-Institute of Science and Innovation for Bio-Sustainability, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.; Centre of Chemistry (CQUM), Department of Chemistry, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal., Gonçalves MST; Centre of Chemistry (CQUM), Department of Chemistry, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal., Preto A; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.; IBS-Institute of Science and Innovation for Bio-Sustainability, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal., Sousa MJ; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.; IBS-Institute of Science and Innovation for Bio-Sustainability, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.

المصدر: Cells [Cells] 2024 Aug 20; Vol. 13 (16). Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Lysosomes*/drug effects , Lysosomes*/metabolism , Oxazines*/pharmacology , Oxazines*/therapeutic use , Antineoplastic Agents*/pharmacology , Cell Proliferation*/drug effects, Humans ; Cell Line, Tumor ; Reactive Oxygen Species/metabolism ; MCF-7 Cells ; Cell Survival/drug effects ; Cell Movement/drug effects

المؤلفون: González-López TJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Bermejo-Vega N; Department of Hematology, Complejo Hospitalario Universitario de Cáceres, Cáceres, Spain., Cardesa-Cabrera R; Department of Hematology, Hospital Público Comarcal de La Merced, Seville, Spain., Martínez-Robles V; Department of Hematology, Complejo Asistencial Universitario de León, León, Spain., Aguilar-Monserrate G; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Pérez-Segura G; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Domingo A; Department of Hematology, Fundació Privada Hospital Asil de Granollers, Barcelona, Spain., Luis-Navarro J; Department of Hematology Hospital General de Riotinto, Minas de Riotinto, Huelva, Spain., Lakhwani S; Department of Hematology, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain., Acedo N; Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain., Lozano ML; Department of Hematology, Hospital General Universitario José María Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, Centro de Investigación Biomédica en Red de Enfermedades Raras- Instituto de Salud Carlos III, Murcia, Spain., Bernat S; Department of Hematology, Hospital Universitario de La Plana, Villareal, Spain., Torres-Tienza A; Department of Hematology, Complejo Asistencial de Segovia, Segovia, Spain., Ruano A; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Jarque I; Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Galán P; Department of Hematology, Complejo Asistencial de Segovia, Segovia, Spain., Benet C; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain., Marcellini S; Department of Hematology, Complejo Asistencial de Segovia, Segovia, Spain., Jimenez-Bárcenas R; Department of Hematology, Hospital de la Serranía de Ronda, Málaga, Spain., Martínez-Carballeira D; Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain., De Miguel-Llorente D; Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain., Perona-Blázquez A; Department of Hematology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain., Gonzalez-Gascón I; Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain., Lopez-Ansoar E; Department of Hematology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Alonso-Alonso JM; Department of Hematology, Complejo Asistencial de Palencia, Palencia, Spain., Bengochea-Casado ML; Department of Hematology, Hospital Universitario Severo Ochoa, Leganés, Spain., Díaz-Gálvez FJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Moretó A; Department of Hematology, Hospital Universitario de Cruces, Barakaldo, Spain., Moreno-Jiménez G; Department of Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Hernández-Martin R; Department of Hematology, Complejo Asistencial de Zamora, Zamora, Spain., de Cabo E; Department of Hematology, Complejo Hospital de El Bierzo, Ponferrada, Spain., Dávila-Valls J; Department of Hematology, Complejo Asistencial de Avila, Avila, Spain., Cuesta A; Department of Hematology, Hospital Sierrallana, Cantabria, Spain., Pastoriza C; Department of Hematology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Hermida-Fernández GJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., García C; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Pozas-Mañas MA; Department of Hematology, Hospital Universitario Río Hortega, Valladolid, Spain., Aguilar C; Department of Hematology, Complejo Asistencial de Soria, Soria, Spain., Fernandez-Jimenez D; Department of Hematology, Hospital Universitario Clínico San Cecilio, Granada, Spain., Navas-Elorza B; Department of Hematology, Hospital Clínico San Carlos, Madrid, Spain., López-Santamaría Castro C; Department of Hematology, Hospital Universitario de Badajoz, Badajoz, Spain., Lorenzo A; Department of Hematology, Hospital Universitario Lucus Augusti, Lugo, Spain., Ortín X; Department of Hematology, Hospital Verge de la Cinta, Tortosa, Spain., García M; Department of Hematology, Hospital de Terrassa, Barcelona, Spain., Piernas S; Department of Hematology, Parc Taulí Hospital Universitari, Sabadell, Spain., Díaz-Santa J; Department of Hematology, Hospital Universitari Doctor Josep Trueta, Girona, Spain., Soto I; Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain., Provan D; Department of Haematology, Barts and The London School of Medicine, London, United Kingdom., García-Donas Gabaldón G; Department of Hematology, Hospital Universitario Virgen Macarena, Seville, Spain.

المصدر: Blood [Blood] 2024 Aug 08; Vol. 144 (6), pp. 646-656.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Purpura, Thrombocytopenic, Idiopathic*/drug therapy , Oxazines*/therapeutic use , Oxazines*/adverse effects , Pyrimidines*/therapeutic use , Pyrimidines*/adverse effects , Morpholines*/therapeutic use , Morpholines*/adverse effects , Pyridines*/therapeutic use , Pyridines*/adverse effects , Aminopyridines*/therapeutic use , Aminopyridines*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Aged, 80 and over ; Retrospective Studies ; Treatment Outcome ; Syk Kinase/antagonists & inhibitors ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Platelet Count ; Prospective Studies

المؤلفون: Ai J; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Li J; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Chang AK; College of Life and Environmental Sciences, Wenzhou University, Wenzhou 325035, Zhejiang Province, PR China., Pei Y; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Li H; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Liu K; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Li R; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Xu L; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Wang N; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Liu Y; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Su W; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Liu W; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Wang T; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China., Jiang Z; Department of Analytical Chemistry, College of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning Province, PR China., Chen L; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China. Electronic address: clj1172023@163.com., Liang X; School of Pharmaceutical Sciences, Liaoning University, 66 Chongshan Road, Shenyang 110036, Liaoning Province, PR China. Electronic address: liangxiao3232@163.com.

المصدر: Pesticide biochemistry and physiology [Pestic Biochem Physiol] 2024 Aug; Vol. 203, pp. 106024. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 1301573 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9939 (Electronic) Linking ISSN: 00483575 NLM ISO Abbreviation: Pestic Biochem Physiol Subsets: MEDLINE

مواضيع طبية MeSH: Oxazines*/pharmacokinetics , Oxazines*/toxicity , Oxazines*/metabolism , Insecticides*/toxicity , Insecticides*/pharmacokinetics , Insecticides*/chemistry , Biological Availability* , Toxicokinetics* , Rats, Sprague-Dawley*, Animals ; Male ; Stereoisomerism ; Rats

المؤلفون: Peinador RI; Institut de la Filtration et des Techniques Séparatives (IFTS), Rue Marcel Pagnol, 47510 Foulayronnes, France. Electronic address: rene.peinador@ifts-sls.com., H P PT; Institut de la Filtration et des Techniques Séparatives (IFTS), Rue Marcel Pagnol, 47510 Foulayronnes, France., Calvo JI; Departamento de Física Aplicada, ETSIIAA, Universidad de Valladolid, Avenida de Madrid 57, 34004 Palencia, Spain; Institute of Sustainable Processes (ISP), Dr. Mergelina s/n, 47071, Valladolid, Spain.

المصدر: Chemosphere [Chemosphere] 2024 Aug; Vol. 362, pp. 142609. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 0320657 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1298 (Electronic) Linking ISSN: 00456535 NLM ISO Abbreviation: Chemosphere Subsets: MEDLINE

مواضيع طبية MeSH: Oxazines*/chemistry , Oxazines*/analysis , Water Pollutants, Chemical*/analysis , Environmental Monitoring*/methods, Microplastics/analysis ; Seawater/chemistry ; Wastewater/chemistry ; Wastewater/analysis ; Plastics/analysis ; Plastics/chemistry ; Fluorescent Dyes/chemistry ; Nanoparticles/chemistry

المؤلفون: Xu Y; Institute of Neuroscience and Brain Disease, Department of Pain, Xiangyang Central Hospital, Hubei University of Arts and Science, Hubei, China., Jiang F; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China., Shi S; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China., Zheng H; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China., Li X; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China., Ye X; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China. yezi703@126.com., Gong X; Institute of Neuroscience and Brain Disease, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, No.136. Jinzhou Street, Xiangcheng District, Xiangyang, 441000, China. gongxrhbxy@sohu.com.

المصدر: BMC anesthesiology [BMC Anesthesiol] 2024 Jul 30; Vol. 24 (1), pp. 261. Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968535 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2253 (Electronic) Linking ISSN: 14712253 NLM ISO Abbreviation: BMC Anesthesiol Subsets: MEDLINE

مواضيع طبية MeSH: Analgesia, Patient-Controlled*/methods , Benzamides*/therapeutic use , Benzamides*/administration & dosage , Chronic Pain*/drug therapy , Chronic Pain*/prevention & control , Oxazines*/administration & dosage , Oxazines*/therapeutic use , Pain, Postoperative*/drug therapy , Pain, Postoperative*/prevention & control, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Analgesics, Opioid/therapeutic use ; Analgesics, Opioid/administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic ; Double-Blind Method ; Lung/surgery ; Serotonin 5-HT3 Receptor Antagonists/administration & dosage ; Serotonin 5-HT3 Receptor Antagonists/therapeutic use

المؤلفون: Khollat A; Department of Organic Chemistry, Faculty of Chemistry, University of Kashan, P.O. Box 8731753153, Kashan, Iran., Moradi L; Department of Organic Chemistry, Faculty of Chemistry, University of Kashan, P.O. Box 8731753153, Kashan, Iran. l_moradi@kashanu.ac.ir.

المصدر: Scientific reports [Sci Rep] 2024 Jul 13; Vol. 14 (1), pp. 16211. Date of Electronic Publication: 2024 Jul 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Docking Simulation* , Breast Neoplasms*/drug therapy , Oxazines*/chemistry , Oxazines*/chemical synthesis, Catalysis ; Humans ; Female ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemical synthesis ; Spectroscopy, Fourier Transform Infrared ; Green Chemistry Technology/methods

المؤلفون: Li M; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland., Cruz CD; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland., Ilina P; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland., Tammela P; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland. paivi.tammela@helsinki.fi.

المصدر: Archives of microbiology [Arch Microbiol] 2024 Jul 05; Vol. 206 (8), pp. 344. Date of Electronic Publication: 2024 Jul 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0410427 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-072X (Electronic) Linking ISSN: 03028933 NLM ISO Abbreviation: Arch Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Biofilms*/drug effects , Biofilms*/growth & development , Uropathogenic Escherichia coli*/drug effects , Uropathogenic Escherichia coli*/physiology , High-Throughput Screening Assays*/methods , Xanthenes*/chemistry , Anti-Bacterial Agents*/pharmacology , Gentian Violet*/metabolism , Oxazines*/pharmacology , Oxazines*/metabolism , Oxazines*/chemistry, Microbial Sensitivity Tests ; Urinary Tract Infections/microbiology ; Humans

المؤلفون: Turkova A; Medical Research Council Clinical Trials Unit at University College London, UK. Electronic address: a.turkova@ucl.ac.uk., Chan MK; Medical Research Council Clinical Trials Unit at University College London, UK., Kityo C; Joint Clinical Research Centre, Kampala, Uganda., Kekitiinwa AR; Baylor College of Medicine, Kampala, Uganda., Musoke P; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Violari A; Perinatal HIV Research Unit, University of the Witwarsrand, Johannesburg, South Africa., Variava E; Perinatal HIV Research Unit, University of the Witwarsrand, Johannesburg, South Africa., Archary M; Department of Paediatrics and Children Health, King Edward VIII Hospital, Enhancing Care Foundation, University of KwaZulu-Natal, Durban, South Africa., Cressey TR; AMS-IRD PHPT Research Collaboration, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Chalermpantmetagul S; AMS-IRD PHPT Research Collaboration, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Sawasdichai K; Prapokklao Hospital, Chantaburi, Thailand., Ounchanum P; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand., Kanjanavanit S; Nakornping Hospital, Chiang Mai, Thailand., Srirojana S; Kalasin Hospital, Kalasin, Thailand., Srirompotong U; Khon Kaen Hospital, Khon Kaen, Thailand., Welch S; Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Bamford A; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; University College London Great Ormond Street Institute of Child Health, London, UK., Epalza C; Instituto de Investigación Sanitaria Hospital, 12 de Octubre (imas12), Madrid, Spain., Fortuny C; Infectious Diseases Department, Institut de Recerca Sant Joan de Déu, Sant Joan de Déu Children's Hospital, Barcelona, Spain; Department of Surgery and Medico-Surgical Specialties, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Colbers A; Department of Pharmacy, Radboud Institute for Medical InnovationHealth Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Nastouli E; University College London Great Ormond Street Institute of Child Health, London, UK; University College London Hospitals NHS Trust, Advanced Pathogen Diagnostics Unit, London, UK., Walker S; Centre for Health Economics, University of York, Heslington, York, UK., Carr D; Department of Molecular and Clinical Pharmacology, University of Liverpool, UK., Conway M; Fondazione Penta ETS, Padova, Italy., Spyer MJ; Medical Research Council Clinical Trials Unit at University College London, UK; University College London Great Ormond Street Institute of Child Health, London, UK., Parkar N; Medical Research Council Clinical Trials Unit at University College London, UK., White I; Medical Research Council Clinical Trials Unit at University College London, UK., Nardone A; Fondazione Penta ETS, Padova, Italy., Thomason MJ; Medical Research Council Clinical Trials Unit at University College London, UK., Ferrand RA; London School of Hygiene and Tropical Medicine, UK., Giaquinto C; Fondazione Penta ETS, Padova, Italy; University of Padova, Department of Women and Child Health, Padova, Italy., Ford D; Medical Research Council Clinical Trials Unit at University College London, UK.

مؤلفون مشاركون: D3 trial team

المصدر: Contemporary clinical trials [Contemp Clin Trials] 2024 Jul; Vol. 142, pp. 107540. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Heterocyclic Compounds, 3-Ring*/administration & dosage , Heterocyclic Compounds, 3-Ring*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/therapeutic use , HIV Infections*/drug therapy , HIV-1*/drug effects , Lamivudine*/administration & dosage , Lamivudine*/therapeutic use , Oxazines*/administration & dosage , Oxazines*/therapeutic use , Piperazines*/administration & dosage , Pyridones*/administration & dosage , Pyridones*/therapeutic use , Pyridones*/pharmacokinetics, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Male ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacokinetics ; Drug Combinations ; Drug Therapy, Combination ; Equivalence Trials as Topic ; Reverse Transcriptase Inhibitors/administration & dosage ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/pharmacokinetics ; RNA, Viral ; Viral Load

المؤلفون: Waalewijn H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Bamford A; Medical Research Council Clinical Trials Unit, University College London, London, UK.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, UK., Gibb DM; Medical Research Council Clinical Trials Unit, University College London, London, UK., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Colbers A; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

مؤلفون مشاركون: CHAPAS-4 trial team

المصدر: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Sep 26; Vol. 13 (9), pp. 496-500.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN: 2048-7207 (Electronic) Linking ISSN: 20487193 NLM ISO Abbreviation: J Pediatric Infect Dis Soc Subsets: MEDLINE

مواضيع طبية MeSH: Pyridones*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/blood , Heterocyclic Compounds, 3-Ring*/administration & dosage , Oxazines*/pharmacokinetics , Piperazines*/pharmacokinetics , HIV Infections*/drug therapy , Anti-HIV Agents*/pharmacokinetics , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/blood , Anti-HIV Agents*/administration & dosage, Humans ; Child ; Male ; Female ; Tenofovir/pharmacokinetics ; Tenofovir/therapeutic use ; Child, Preschool ; Adolescent ; Emtricitabine/pharmacokinetics ; Emtricitabine/therapeutic use ; Emtricitabine/administration & dosage ; Dideoxynucleosides/pharmacokinetics ; Dideoxynucleosides/therapeutic use ; Dideoxynucleosides/administration & dosage ; Lamivudine/pharmacokinetics ; Lamivudine/therapeutic use ; Lamivudine/administration & dosage ; HIV Integrase Inhibitors/pharmacokinetics ; HIV Integrase Inhibitors/therapeutic use ; HIV Integrase Inhibitors/administration & dosage ; Alanine/pharmacokinetics ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Biological Availability ; Drug Therapy, Combination ; Zidovudine/pharmacokinetics ; Zidovudine/therapeutic use ; Zidovudine/administration & dosage ; Adenine/analogs & derivatives ; Adenine/pharmacokinetics ; Adenine/therapeutic use ; Drug Interactions